Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Genetic Variants Associated With Enalapril-Induced Adverse Drug Reaction and Impact of Pharmacogenomics on First Stroke in Hypertensive Patients Taking Enalapril or Enalapril-Folic Acid Therapy.

NCT03259399 is registered in ClinicalTrials.gov with Cui Yimin as lead sponsor.

NCT NCT03259399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03259399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Genetic Variants Associated With Enalapril-Induced Adverse Drug Reaction and Impact of Pharmacogenomics on First Stroke in Hypertensive Patients Taking Enalapril or Enalapril-Folic Acid Therapy.
Lead sponsor
Cui Yimin
Phase
Observational
Overall status
Unknown status
Start date
August 16, 2017
Completion date
June 30, 2020
Enrollment
2,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enalapril adverse reaction, pharmacogenomics, stroke